IGC Pharma Gestion
Gestion contrôle des critères 1/4
IGC Pharma's CEO is Ram Mukunda, appointed in Apr 2005, has a tenure of 19.58 years. total yearly compensation is $1.82M, comprised of 19.8% salary and 80.2% bonuses, including company stock and options. directly owns 5.76% of the company’s shares, worth $1.68M. The average tenure of the management team and the board of directors is 6.8 years and 2.8 years respectively.
Informations clés
Ram Mukunda
Directeur général
US$1.8m
Rémunération totale
Pourcentage du salaire du PDG | 19.8% |
Durée du mandat du directeur général | 19.6yrs |
Propriété du PDG | 5.8% |
Durée moyenne d'occupation des postes de direction | 6.8yrs |
Durée moyenne du mandat des membres du conseil d'administration | 2.8yrs |
Mises à jour récentes de la gestion
Analyse de la rémunération des PDG
Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -US$13m |
Mar 31 2024 | US$2m | US$360k | -US$13m |
Dec 31 2023 | n/a | n/a | -US$14m |
Sep 30 2023 | n/a | n/a | -US$11m |
Jun 30 2023 | n/a | n/a | -US$11m |
Mar 31 2023 | US$1m | US$360k | -US$12m |
Dec 31 2022 | n/a | n/a | -US$14m |
Sep 30 2022 | n/a | n/a | -US$14m |
Jun 30 2022 | n/a | n/a | -US$16m |
Mar 31 2022 | US$6m | US$320k | -US$15m |
Dec 31 2021 | n/a | n/a | -US$11m |
Sep 30 2021 | n/a | n/a | -US$11m |
Jun 30 2021 | n/a | n/a | -US$9m |
Mar 31 2021 | US$801k | US$292k | -US$9m |
Dec 31 2020 | n/a | n/a | -US$9m |
Sep 30 2020 | n/a | n/a | -US$8m |
Jun 30 2020 | n/a | n/a | -US$8m |
Mar 31 2020 | US$719k | US$300k | -US$7m |
Dec 31 2019 | n/a | n/a | -US$6m |
Sep 30 2019 | n/a | n/a | -US$5m |
Jun 30 2019 | n/a | n/a | -US$5m |
Mar 31 2019 | US$712k | US$300k | -US$4m |
Dec 31 2018 | n/a | n/a | -US$3m |
Sep 30 2018 | n/a | n/a | -US$2m |
Jun 30 2018 | n/a | n/a | -US$2m |
Mar 31 2018 | US$469k | US$300k | -US$2m |
Rémunération vs marché: Ram's total compensation ($USD1.82M) is above average for companies of similar size in the US market ($USD655.65K).
Rémunération et revenus: Ram's compensation has increased whilst the company is unprofitable.
PDG
Ram Mukunda (65 yo)
19.6yrs
Titularisation
US$1,821,000
Compensation
Mr. Ram Mukunda is the Founder of IGC Pharma, Inc. (formerly known as India Globalization Capital, Inc.) and has been Chief Executive Officer, President and Executive Director since April 29, 2005. He is r...
Équipe de direction
Nom | Position | Titularisation | Compensation | Propriété |
---|---|---|---|---|
President | 19.6yrs | US$1.82m | 5.76% $ 1.7m | |
VP, Principal Financial Officer | 6.5yrs | US$717.00k | 1.37% $ 399.6k | |
Director of Operations | less than a year | pas de données | pas de données | |
Senior Director of Accounting & Principal Accounting Officer | 7.2yrs | US$41.00k | pas de données |
6.8yrs
Durée moyenne de l'emploi
52yo
Âge moyen
Gestion expérimentée: IGC's management team is seasoned and experienced (6.8 years average tenure).
Membres du conseil d'administration
Nom | Position | Titularisation | Compensation | Propriété |
---|---|---|---|---|
President | 19.6yrs | US$1.82m | 5.76% $ 1.7m | |
VP, Principal Financial Officer | 2.7yrs | US$717.00k | 1.37% $ 399.6k | |
Independent Chairman of the Board | 17.5yrs | US$259.00k | 1.38% $ 401.8k | |
Independent Director | less than a year | US$49.00k | 0.038% $ 11.2k | |
Independent Director | 2.8yrs | US$185.00k | 1.25% $ 363.1k |
2.8yrs
Durée moyenne de l'emploi
67yo
Âge moyen
Conseil d'administration expérimenté: IGC's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.